Página principal > Resultados de la búsqueda: Brealey, David
  Consejos para la búsqueda
Búsqueda simple
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.01 segundos. 
1.
9 p, 536.9 KB Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome : Study protocol for a randomized controlled trial / Bellingan, Geoff (University College London Hospitals) ; Brealey, David (University College London Hospitals) ; Mancebo, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Mercat, Alain (CHU D'Angers) ; Patroniti, Nicolò (Azienda Ospedaliera San Gerardo) ; Pettilä, Ville (Helsinki University Hospital) ; Quintel, Michael (Universitätsmedizin Göttingen) ; Vincent, Jean-Louis (Université libre de Bruxelles) ; Maksimow, Mikael (Faron Pharmaceuticals Oy) ; Jalkanen, Markku (Faron Pharmaceuticals Oy) ; Piippo, Ilse (Faron Pharmaceuticals Oy) ; Ranieri, V.Marco (Sapienza University of Rome) ; Universitat Autònoma de Barcelona
Acute respiratory distress syndrome (ARDS) results in vascular leakage, inflammation and respiratory failure. There are currently no approved pharmacological treatments for ARDS and standard of care involves treatment of the underlying cause, and supportive care. [...]
2017 - 10.1186/s13063-017-2234-7
Trials, Vol. 18 Núm. 1 (13 2017) , p. 536  
Registro completo - Creative Commons
2.
11 p, 838.8 KB Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia : a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study) / Welte, Tobias (Carl-Neuberg-Str. 1, 30625 Hannover, Germany) ; Dellinger, R. Phillip (Cooper Medical School of Rowan University. Department of Medicine) ; Ebelt, Henning (Universitätsklinikum Halle (Saale). Klinik und Poliklinik für Innere Medizin III) ; Ferrer, Miguel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Opal, Steven M. (Rhode Island Hospital. Infectious Disease Division) ; Singer, Mervyn (University College London. Bloomsbury Institute of Intensive Care Medicine) ; Vincent, Jean-Louis (Erasme University Hospital. Department of Intensive Care) ; Werdan, Karl (St. James's Hospital. Trinity Centre for Health Sciences) ; Martin-Loeches, Ignacio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Almirall i Pujol, Jordi (Hospital de Mataró. Consorci Sanitari del Maresme) ; Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Ignacio Ayestarán, Jose (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Nuding, Sebastian (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Ferrer, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sirgo Rodríguez, Gonzalo (Hospital Universitari Joan XXIII de Tarragona) ; Shankar-Hari, Manu (Guy's and St. Thomas' NHS Foundation Trust. Intensive Care Medicine) ; Álvarez Lerma, Francisco (Hospital del Mar (Barcelona, Catalunya)) ; Riessen, Reimer (Universitätsklinikum Tübingen. Internistische Intensivstation) ; Sirvent, Josep-Maria (Hospital Universitari de Girona Doctor Josep Trueta) ; Kluge, Stefan (Universitätsklinikum Hamburg-Eppendorf. Klinik für Intensivmedizin) ; Zacharowski, Kai (Universitätsklinikum Frankfurt. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie) ; Bonastre Mora, Juan (Hospital Universitari i Politècnic La Fe (València)) ; Lapp, Harald (Medizinische Klinik, Kardiologie und Intensivmedizin, Helios Klinikum Erfurt, Erfurt, Germany) ; Wöbker, Gabriele (Klinik für Intensivmedizin, Helios Universitätsklinikum Wuppertal, Wuppertal, Germany) ; Achtzehn, Ute (Klinikum Chemnitz gGmbH. Innere Medizin IV - Pneumologie) ; Brealey, David (Critical Care Unit, NIHR University College London Hospitals Biomedical Research Centre, University College London Hospitals, NHS Foundation Trust, London, UK) ; Kempa, Axel (Katharinenhospital, Stuttgart. Klinik für Allgemeine Innere Medizin) ; Sánchez García, Miguel (Hospital Clínico San Carlos (Madrid)) ; Brederlau, Jörg (Helios Klinikum Berlin-Buch, Klinik für Intensivmedizin) ; Kochanek, Matthias (University Hospital of Cologne. Department I of Internal Medicine) ; Reschreiter, Henrik Peer (Poole Hospital NHS Foundation Trust) ; Wise, Matthew P. (Heath Park, Cardiff) ; Belohradsky, Bernd H. (University Children's Hospital Munich) ; Bobenhausen, Iris (Biotest AG) ; Dälken, Benjamin (Biotest AG) ; Dubovy, Patrick (Biotest AG) ; Langohr, Patrick (Biotest AG) ; Mayer, Monika (Biotest AG) ; Schüttrumpf, Jörg (Biotest AG) ; Wartenberg-Demand, Andrea (Biotest AG) ; Wippermann, Ulrike (Biotest AG) ; Wolf, Daniele (Biotest AG) ; Torres, Antoni (Hospital Clínic i Provincial de Barcelona)
The CIGMA study investigated a novel human polyclonal antibody preparation (trimodulin) containing ~ 23% immunoglobulin (Ig) M, ~ 21% IgA, and ~ 56% IgG as add-on therapy for patients with severe community-acquired pneumonia (sCAP). [...]
2018 - 10.1007/s00134-018-5143-7
Intensive Care Medicine, Vol. 44 (april 2018) , p. 438-448  
Registro completo - Creative Commons

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos